199 related articles for article (PubMed ID: 12119888)
1. [Coxib spares the stomach. This is true also for patients with preventive aspirin administration].
MMW Fortschr Med; 2002 May; 144(20):62. PubMed ID: 12119888
[No Abstract] [Full Text] [Related]
2. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
Zeidler H
MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
[No Abstract] [Full Text] [Related]
3. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
Eisen GM; Goldstein JL; Hanna DB; Rublee DA
Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
[TBL] [Abstract][Full Text] [Related]
5. [Symptomatic therapy of arthrosis and rheumatoid arthritis. Who will benefit from Coxib?].
MMW Fortschr Med; 2002 Apr; 144(14):53. PubMed ID: 12014284
[No Abstract] [Full Text] [Related]
6. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
7. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
8. [Celecoxib and the CLASS study--worse and worse...].
Slørdal L
Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2219. PubMed ID: 12426903
[No Abstract] [Full Text] [Related]
9. [Celebrex: confirmed effectiveness and safety (new data)].
Nasonov EL
Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
[No Abstract] [Full Text] [Related]
10. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
[No Abstract] [Full Text] [Related]
11. A safe non-steroidal anti-inflammatory drug--the search continues.
Lanza FL
Ital J Gastroenterol Hepatol; 1999; 31(5):386-7. PubMed ID: 10470597
[No Abstract] [Full Text] [Related]
12. [Celecoxib and the CLASS study--a statement].
Wibe E; Maehlum S
Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2218. PubMed ID: 12426902
[No Abstract] [Full Text] [Related]
13. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol (Cytotec) in NSAID gastropathy.
Habibullah CM; Singh SP; Phaterpekar SJ
J Assoc Physicians India; 1993 Nov; 41(11):770. PubMed ID: 8005958
[No Abstract] [Full Text] [Related]
15. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
Greenberg JD; Bingham CO; Abramson SB; Reed G; Sebaldt RJ; Kremer J
Arthritis Rheum; 2005 Feb; 53(1):12-7. PubMed ID: 15696570
[TBL] [Abstract][Full Text] [Related]
16. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
17. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
[No Abstract] [Full Text] [Related]
18. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
Maetzel A; Krahn M; Naglie G
Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
[TBL] [Abstract][Full Text] [Related]
19. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
20. [The future of peptic ulcer disease without Helicobacter].
Lehmann FS; Gyr N
Praxis (Bern 1994); 2003 Mar; 92(12):547-50. PubMed ID: 12693146
[No Abstract] [Full Text] [Related]
[Next] [New Search]